Stock Price
74.30
Daily Change
-0.06 -0.08%
Monthly
1.50%
Yearly
-21.59%
Q2 Forecast
72.12

Symrise reported EUR1.15B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Avient USD 761M 46M Dec/2025
Chemours USD 1.3B 200M Dec/2025
Corteva USD 3.91B 1.29B Dec/2025
Covestro EUR 2.92B 255M Dec/2025
Symrise EUR 1.15B 70M Dec/2025
Victrex GBP 75.5M 70.4M Sep/2025